Our Impact

ANDHealth’s impact to date:

As at 30 June 2025.
1120+
Companies screened
and supported
3710+
Hours of direct
program support
4250+
Total program
participants
2.9M+
Patients impacted
by cohort companies
28
ANDHealth+ cohort
companies
45
ACTIVATE cohort
companies
229
Masterclass program
participants
546
BRIGHT program
participants
1140+
Office Hours
delivered
8110+
Total event
attendees
2710+
Total CHICC
visitors
260+
International
delegates

ANDHealth+ is Australia's leading health accelerator

$15.5M of non-dilutive funding deployed into 28 portfolio companies as of 30 September 2025.
$195M
Raised (dilutive &
non-dilutive)
$81.8M
New revenue
generated
517
New jobs (FTE)
created
3,453,349
New patients
impacted
981
Commercial pilots
commenced
110
Clinical trials and
studies commenced
1892
New commercial
customers
42
New international
market launches
34.1
New CxO roles
(FTE)
162
New partnerships
formed
22
New regulatory
approvals
4
Exits
n= 28 companies. 21 MRFF funded companies reporting. 6 pilot companies ceased reporting Mar 2023 (3 pilot companies also selected in MRFF cohorts). FY18 Pilot Cohort onboarded Oct 2017 | FY19 Pilot Cohort onboarded Sept 2018 | MRFF Cohort 1 onboarded Jan 2022 | MRFF Cohort 2 onboarded Jan 2023 | MRFF Cohort 3 onboarded Sept 2023 | MRFF Cohort 4 onboarded April 2024
An independent report by L.E.K. Consulting has highlighted the considerable impact of ANDHealth+ on core economic metrics when benchmarked against comparable accelerators:
  • 1.9x more capital raised compared to non-ANDHealth+ digital health companies
  • 1.4x more jobs created compared to non-ANDHealth+ digital health companies
  • 2.5x – 13x more capital raised compared to non-ANDHealth+ accelerator portfolios
  • 1.6x – 4.7x more jobs created compared to non-ANDHealth+ accelerator portfolios
  • $19.7 of capital raised for every $1 of ANDHealth+ investment
  • $6.7 of revenue earnt for every $1 of ANDHealth+ investment
  • 87 patients impacted for every $1k of ANDHealth+ investment
  • 56 new jobs created for every $1M of ANDHealth+ investment
Learn more

What our program participants say:

It has been a privilege to participate in the ANDHealth+ program.
The value that we have gained from the in-house ANDHealth expertise, their international top-tier network, and the funding to support essential commercial and clinical projects has been absolutely essential in propelling us towards our next level of growth. The deep know-how of the ANDHealth+ team has been an essential part of our recent achievements.
Tara Croft
CEO, Baymatob
Participating in the ANDHealth+ program has been hugely impactful for Perx Health. The guidance and support we received helped to accelerate our growth, enhancing our investment prospects and deepening our understanding of the digital health market. This program has empowered us to deliver greater impact for our enterprise customers, and the people we serve, improving health outcomes across the board.
Hugo Rourke
CEO, Perx Health
ANDHealth Masterclass is simply a must-do for any company seeking to commercialise a digital health product. The program provided us access to world-leading experts across corporate governance, risk management and sales, specifically targeted to the health technology industry. The six days spent in this program is some of the most valuable time you will spend developing your digital health commercialisation strategy.
Emerson Keenan
CEO, Kali Healthcare
ANDHealth fill a niche that is otherwise a critical gap in our digital health and medtech ecosystem – important not just for budding digital health tech start-ups, but also for all stages of product development.

The Digital Health Summit offered top shelf and diverse expert presenters. I'll be back for future events and can highly recommend!
Anonymous
Event Attendee

Join our
mailing list

Stay up to date on news, programs and events